Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Other Non-Current Assets: 2022-2024

Historic Other Non-Current Assets for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $1.0 million.

  • Orchestra BioMed Holdings' Other Non-Current Assets fell 0.54% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 0.54%. This contributed to the annual value of $1.0 million for FY2024, which is 32.64% up from last year.
  • Orchestra BioMed Holdings' Other Non-Current Assets amounted to $1.0 million in FY2024, which was up 32.64% from $769,000 recorded in FY2023.
  • Over the past 5 years, Orchestra BioMed Holdings' Other Non-Current Assets peaked at $4.7 million during FY2022, and registered a low of $769,000 during FY2023.
  • Its 3-year average for Other Non-Current Assets is $2.2 million, with a median of $1.0 million in 2024.
  • In the last 5 years, Orchestra BioMed Holdings' Other Non-Current Assets plummeted by 83.68% in 2023 and then spiked by 32.64% in 2024.
  • Over the past 3 years, Orchestra BioMed Holdings' Other Non-Current Assets (Yearly) stood at $4.7 million in 2022, then tumbled by 83.68% to $769,000 in 2023, then spiked by 32.64% to $1.0 million in 2024.